APOTHEEK DELESTRE
ActiveAPOTHEEK DELESTRE has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €382k and a net result of €43k. Equity is growing by ~7.7% per year across the filed fiscal years. Its solvency ranks better than 76% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2024
80
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability78▲+8
Solvency88▲+2
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 2.75 against 2.51 in 2023; short-term debt: 35% and cash: 28.5% of total assets), and 36.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 16-10-2025, 77 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
77 d late
2023
30 d late
2022
29 d late
2021
54 d late
2020
31 d late
2019
101 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€382k▲ 12.7%
2023 · €339k
2018: €472k
2019: €253k
2020: €267k
2021: €293k
2022: €319k
2023: €339k
2018 → 2024
Total assets
€602k▲ 8.5%
2023 · €555k
2018: €648k
2019: €440k
2020: €463k
2021: €464k
2022: €510k
2023: €555k
2018 → 2024
Net result
€43k▲ 110%
2023 · €20k
2018: €29k
2019: €23k
2020: €14k
2021: €26k
2022: €26k
2023: €20k
2018 → 2024
Working capital
€369k▲ 16.1%
2023 · €318k
2018: €461k
2019: €251k
2020: €266k
2021: €291k
2022: €297k
2023: €318k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€267k-€293k▲ 9.7%€319k▲ 8.8%€339k▲ 6.4%€382k▲ 12.7%
Operating result€25k-€41k▲ 60.2%€40k▼ 2.2%€36k▼ 9.9%€64k▲ 78.0%
Net result€14k-€26k▲ 78.1%€26k▲ 0.3%€20k▼ 20.9%€43k▲ 110%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 78% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €602k
Fixed assets
€22k▼ 16.5%
Current assets
€580k▲ 9.8%
Equity and liabilities €602k
Equity
€382k▲ 12.7%
Debt
€220k▲ 2.0%
The debt ratio falls from 38.9% to 36.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€72k▲
2023 · €43k
Cash flow
€51k▲
2023 · €28k
Solvency
63.5%▲
2023 · 61.1%
Current ratio
2.75▲
2023 · 2.51
Quick ratio
2.12▲
2023 · 1.98
Debt / equity
0.58▼
2023 · 0.64
ROE
11.2%▲
2023 · 6.0%
ROA
7.1%▲
2023 · 3.7%
Interest coverage
6.37▲
2023 · 5.54
Debt
€220k▲
2023 · €216k
Debt ≤ 1 year
€211k▲
2023 · €210k
Income taxes
€16k▲
2023 · €8k
Staff costs
€167k▼
2023 · €169k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€555k€602k▲
Fixed assets21/28€27k€22k▼
Tangible fixed assets22/27€27k€22k▼
Furniture and vehicles24€27k€22k▼
Current assets29/58€528k€580k▲
Amounts receivable after more than one year29€107€107=
Other amounts receivable291€107€107=
Stocks and contracts in progress3€112k€133k▲
Stocks30/36€112k€133k▲
Amounts receivable within one year40/41€87k€72k▼
Trade receivables40€87k€72k▼
Current investments50/53€200k€200k=
Cash at bank and in hand54/58€125k€171k▲
Deferred charges and accrued income490/1€5k€3k▼
Equity and liabilities
Total equity and liabilities10/49€555k€602k▲
Equity10/15€339k€382k▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€277k€320k▲
Non-distributable reserves130/1€13k€13k=
Legal reserve130€13k€13k=
Distributable reserves133€264k€307k▲
Amounts payable17/49€216k€220k▲
Amounts payable within one year42/48€210k€211k▲
Trade debts44€43k€38k▼
Suppliers440/4€43k€38k▼
Taxes, remuneration and social security45€31k€31k=
Taxes450/3€8k€13k▲
Remuneration and social security454/9€22k€17k▼
Other amounts payable47/48€137k€142k▲
Accrued charges and deferred income492/3€5k€9k▲
Income statement
Code20232024
Remuneration, social security and pensions62€169k€167k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€8k▲
Other operating charges640/8€955€875▼
Gross operating margin9900€213k€240k▲
Operating profit (loss)9901€36k€64k▲
Financial income75/76B€178€7k▲
Recurring financial income75€178€7k▲
Financial charges65/66B€8k€11k▲
Recurring financial charges65€8k€11k▲
Profit (loss) for the period before taxes9903€28k€59k▲
Income taxes67/77€8k€16k▲
Profit (loss) for the period9904€20k€43k▲
Profit (loss) for the period to be appropriated9905€20k€43k▲
Appropriation of the result
Profit (loss) to be appropriated9906€20k€43k▲
Transfer to equity691/2€20k€43k▲
To other reserves6921€20k€43k▲
Social balance
Average headcount (FTE)90871.81.6▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
16-10
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 77 days late
2024
31-12
Financial
Highest result since 2018net €43k ▲110%
Operating result €64k, net result €43k, both a record.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 29 days late
2022
23-09
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 54 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
31-12
Financial
Weakest financial yearnet €14k ▼38.2%
Net result drops to €14k, the lowest in the series; recovery starts the following year.
09-11
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 101 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 28 days late
2017
19-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
29-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Denderleeuw · 1 establishment unit since 1996
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Brandweerstraat 149470 DenderleeuwGround area
478 m²
Building footprint
219 m²
Volume, LiDAR
1,317 m³
Parcel 41011A1453/00G000, Flanders · tallest building 11.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK DELESTRE NV
since 19962.077.940.730
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41011A1453/00G000 | Flanders | 478 m² | 1 · 219 m² | 11.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteDenderleeuw2.077.940.730
Similar companies · same sector, comparable size
APOTHEEK MARKT MAASEIK
BE 0473.955.460
Maaseik · Eq €382k
APOTHEEK DE PRIL DENDERHOUTEM
BE 0421.416.696
Haaltert · Eq €382k
apotheek Schyvens
BE 0404.191.575
Vorselaar · Eq €383k
PHARMACIE PIERARD
BE 0446.062.814
Gembloux · Eq €382k
PHARMALDEIA
BE 0809.826.868
Gent · Eq €382k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,446 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded17-07-1996
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 29 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.